(Q38200565)

30 August 2017

title

Pediatric-like therapy for adults with ALL. (English)

1 reference

30 August 2017

1

Hervé Dombret

1 reference

30 August 2017

Thomas Cluzeau

2

1 reference

30 August 2017

Françoise Huguet

series ordinal

3

1 reference

30 August 2017

Nicolas Boissel

series ordinal

4

1 reference

30 August 2017

language of work or name

1 reference

1 June 2014

1 reference

Current hematologic malignancy reports

30 August 2017

published in

1 reference

30 August 2017

volume

9

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

158-164

1 reference

Acute lymphoblastic leukaemia

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-014-0210-9

Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol

21 January 2018

1 reference

12 December 2020

Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche de

1 reference

12 December 2020

Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol

1 reference

12 December 2020

Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands

1 reference

12 December 2020

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

1 reference

12 December 2020

Acute lymphoblastic leukemia

1 reference

12 December 2020

Augmented hyper-CVAD based on dose-intensified vincristine, dexamethasone, and asparaginase in adult acute lymphoblastic leukemia salvage therapy

1 reference

12 December 2020

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials

1 reference

12 December 2020

Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both?

1 reference

12 December 2020

10.1007/S11899-014-0210-9

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1010643357

0 references

1 reference